DrWilliam Mendenhall
PROF
MD-RADIATION ONCOLOGY
GRANTS
- GRANTCALGB 30605-RTOG 0972: A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung CancerNational Institute of Health6 Apr 2011 - 13 Sep 2016
- GRANTRTOG 0834/EORTC 26053_22054/NCIC CTG CEC.1 Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q DeletedAnaplastic Glioma: The CATNON Intergroup TrialNational Institute of Health5 Apr 2011 - 13 Dec 2016
- GRANTRTOG 0627National Institute of Health13 Feb 2008 - 19 Sep 2016
- GRANTRTOG 0424: A PHASE II STUDY OF A TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMASNational Institute of Health Nci24 Jul 2006 - 1 Jan 2018
- GRANTA Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or III Breast CancerNational Institute of Health24 Jan 2006 - 1 Sep 2017
- GRANT04052156National Institute of Health3 May 2005 - 1 Jan 2016
- GRANTA PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY(FOLLOWED BY SURGERY FOR RESIDUAL PRIMARY/N2-3 NODAL DISEASE) FOR ADVANCED HEAD AND NECK CARCINOMASNational Institute of Health18 Feb 2005 - 1 Jan 2017
- GRANTA PHASE II RANDOMIZED TRIAL FOR PATIENTS WITH MUSCLE-INVADING BLADDERCANCER EVALUATING TRANSURETHRAL SURGERY AND BID IRRADIATION PLUSEITHER PACLITAXEL AND CISPLATIN OR 5-FLUOROURACIL AND CISPLATINFOLLOWED BY SELECTIVE BLADDER PRESERVATION ANDGEMCNational Institute of Health1 Oct 2004 - 20 Aug 2019
- GRANT02061157National Institute of Health15 Apr 2003 - 1 Jan 2017
- GRANT02061112National Institute of Health23 Aug 2002 - 1 Jan 2017
- GRANT02061124National Institute of Health20 Aug 2002 - 1 Jan 2017